Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive C... ( Shared Physicians Diagnosis ...)

Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care

Date:4/28/2009

Shared Physicians, Diagnosis, Locations, and Research Benefit Regional Cancer Patients

NEW ORLEANS, April 28 /PRNewswire/ -- Ochsner Health System (www.ochsner.org) and LSU Health Sciences Center, New Orleans (www.lsuhsc.edu) have announced a partnership to better serve the region's cancer patients by combining clinical care and cancer research in order to advance patient treatment options and provide better access to care. This collaboration will also further the development of critical, translational research, bridging the gap between research and the delivery of new therapies by allowing research to move rapidly from the laboratory into additional early phase clinical trials and new treatments for cancer patients.

The partnership between the two medical leaders began in 2008 and is centered on combining LSUHSC, the state's largest cancer research facility, with Ochsner, the state's largest clinical cancer provider, to bring better local access to comprehensive cancer care. Patients will benefit from this partnership by having access to the latest research trials and treatments closer to home and the ability to receive comprehensive cancer care through a combined network of local physicians and neighborhood locations. LSUHSC and Ochsner patients will have access to cancer services at both organizations.

"Southeast Louisiana residents will now have a truly diverse 'team' of cancer care experts, clinical experts and research leaders, dedicated to providing compassionate and comprehensive cancer care within the local community," said Dr. John Cole, M.D., Head of Hematology/Oncology at Ochsner Medical Center and Acting Chief of Hematology/Oncology at LSU Health Sciences Center New Orleans. "By combining our expertise, patients will no longer have to travel outside L
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
2. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
6. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
7. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
9. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
10. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
11. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference

Post Your Comments:

Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive C...( Shared Physicians Diagnosis ...)